Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PROSCA/BLADDR 2020 | NMIBC: new approaches

Amir Mostafid, MSc, FRCS, FEBU, Royal Surrey County Hospital, Guildford, Surrey, UK, discusses new approaches in treating non-muscle invasive bladder cancer (NMIBC) including en-bloc resection, genomics, gene sequencing, and improving urine-based biomarkers sensitivity for patients with low-risk NMIBC patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).